Avoro Capital Advisors LLC Relmada Therapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$21.86 - $34.77 $20.4 Million - $32.5 Million	-935,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$29.55 - $39.15 $17.4 Million - $23.1 Million	-590,000 Reduced 38.69%	935,000 $29.9 Million
Q4 2020 Feb 16, 2021	BUY	$29.88 - $39.8 $747,000 - $994,999	25,000 Added 1.67%	1,525,000 $48.9 Million
Q3 2020 Nov 16, 2020	BUY	$34.42 - $43.78 $2.58 Million - $3.28 Million	75,000 Added 5.26%	1,500,000 $56.4 Million
Q2 2020 Aug 14, 2020	BUY	$31.59 - $49.98 $8.69 Million - $13.7 Million	275,000 Added 23.91%	1,425,000 $63.8 Million

Q1 2020 May 15, 2020	BUY	$23.78 - $50.12 $27.3 Million - $57.6 Million	1,150,000 New	1,150,000 $39.2 Million

101

14.3M

82K

73.9K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $85.8M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.